To investigate MBD2's role in inhibiting HNSCC cell growth, we transiently transfected TU212 and AMC‐HN8 cells with shRNA targeting MBD2, followed by 1 μM 5‐Aza treatment for 72 h. The gene discussed is MBD2; the disease is head and neck squamous cell carcinoma.